Bortezomib in Treating Patients With Advanced Non-small Cell Lung Cancer

Clinical trial NCT00040768 · TERMINATED

Trial details

NCT number: NCT00040768
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer

Start date: 2002-04-01
Primary completion: 2006-03-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.